author-photo

Irini Karapanagiotou-Schenkel

Heidelberg University

11

Papers

208

Citations

Citation Trend

Filter By

Papers (8) Sort By

Journal Conference Others

SICKLE CELL DISEASE IN GERMANY IS HETEROGENEOUS AND RESULTS IN SEVERE MORBIDITY: ANALYSES FROM A NATIONAL REGISTRY: PF739

2019
Show All
- Source
- Cite
- Save
Citations (0)
Towards a molecular algorithm predicting glioma treatment response and resistance: A biomarker analysis and path to real time profiling in N2M2.

2018 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Phase 1/2 intra-patient dose escalation study of vorinostat in children with relapsed solid tumor, lymphoma, or leukemia.

2018 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Umbrella protocol for phase I/IIa trials of molecularly matched targeted therapies plus radiotherapy in patients with newly diagnosed glioblastoma without MGMT promoter methylation Neuro Master Match (N{superscript 2}M{superscript 2}).

2016
Show All
- Source
- Cite
- Save
Citations (0)
Phase I/II trial vorinostat in children with relapsed malignancies: interim analysis report

2014 Klinische Padiatrie
Show All
- Source
- Cite
- Save
Citations (0)
Phase I/II intra-patient dose escalation study of vorinostat in children with relapsed solid tumor, lymphoma or leukemia.

2012 Klinische Padiatrie
Show All
- Source
- Cite
- Save
Citations (34)
Randomised trial of proton vs. carbon ion radiation therapy in patients with chordoma of the skull base, clinical phase III study HIT-1-Study

2010 BMC Cancer
Show All
- Source
- Cite
- Save
Citations (65)
An open label randomized multicentre phase IIIb trial comparing parenteral substitution versus best supportive nutritional care in subjects with pancreatic adenocarcinoma receiving 5-FU plus oxaliplatin as 2 nd or higher line chemotherapy regarding clinical benefit - PANUSCO

2009 BMC Cancer
Show All
- Source
- Cite
- Save
Citations (5)